Pfizer Inc. (PFE) Social Stream
Pfizer Inc (PFE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Pfizer Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 21 | $61 | $38 | $46.03 | $42.09 | 9.36% |
The Trend in the Analyst Price Target
PFE's average price target has moved up $3.06 over the prior 72 days.
PFE reports an average of 8.43% for its upside potential over the past 16 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 21 | 61 | 38.0 | 46.03 | 44.20 | 4.14% |
| 2021-09-19 | 21 | 61 | 38.0 | 46.03 | 43.89 | 4.88% |
| 2021-09-18 | 21 | 61 | 38.0 | 46.03 | 43.89 | 4.88% |
| 2021-09-11 | 20 | 61 | 38.0 | 46.23 | 45.59 | 1.4% |
| 2021-09-04 | 19 | 61 | 38.0 | 45.86 | 46.84 | -2.09% |
| 2021-08-28 | 19 | 61 | 38.0 | 45.86 | 46.60 | -1.59% |
| 2021-08-14 | 20 | 53 | 38.0 | 44.32 | 48.48 | -8.58% |
| 2021-08-07 | 20 | 53 | 38.0 | 44.32 | 45.07 | -1.66% |
| 2021-08-05 | 20 | 53 | 38.0 | 44.32 | 45.06 | -1.64% |
| 2021-08-01 | 20 | 53 | 38.0 | 44.02 | 42.81 | 2.83% |
| 2021-07-24 | 21 | 53 | 38.0 | 43.35 | 41.68 | 4.01% |
| 2021-07-17 | 20 | 53 | 38.0 | 43.32 | 40.35 | 7.36% |
| 2021-07-10 | 20 | 53 | 36.0 | 42.97 | 39.61 | 8.48% |
| 2021-07-03 | 20 | 53 | 36.0 | 42.97 | 39.73 | 8.16% |
| 2021-06-26 | 20 | 53 | 36.0 | 42.94 | 38.98 | 10.16% |
| 2021-06-13 | 20 | 53 | 36.0 | 42.69 | 40.15 | 6.33% |
| 2021-06-05 | 19 | 53 | 36.0 | 42.62 | 39.15 | 8.86% |
| 2021-05-22 | 19 | 53 | 36.0 | 42.57 | 39.95 | 6.56% |
| 2021-05-15 | 19 | 53 | 36.0 | 42.57 | 40.02 | 6.37% |
| 2021-05-08 | 19 | 53 | 36.0 | 41.99 | 39.58 | 6.09% |
| 2021-04-25 | 20 | 53 | 36.0 | 40.69 | 38.66 | 5.25% |
| 2021-04-17 | 20 | 53 | 36.0 | 40.69 | 38.57 | 5.5% |
| 2021-04-10 | 20 | 53 | 36.0 | 40.54 | 36.60 | 10.77% |
| 2021-04-03 | 20 | 53 | 36.0 | 40.54 | 36.30 | 11.68% |
| 2021-03-20 | 20 | 53 | 36.0 | 40.99 | 35.53 | 15.37% |
| 2021-03-13 | 20 | 53 | 36.0 | 40.99 | 34.94 | 17.32% |
| 2021-03-06 | 20 | 53 | 36.0 | 41.09 | 34.39 | 19.48% |
| 2021-02-27 | 20 | 53 | 36.0 | 41.09 | 33.49 | 22.69% |
| 2021-02-20 | 20 | 53 | 36.0 | 41.09 | 34.44 | 19.31% |
| 2021-02-13 | 20 | 53 | 36.0 | 41.09 | 34.72 | 18.35% |
| 2021-02-06 | 20 | 53 | 36.0 | 41.14 | 34.92 | 17.81% |
| 2021-01-30 | 20 | 53 | 36.0 | 41.49 | 35.90 | 15.57% |
| 2021-01-23 | 19 | 53 | 36.0 | 41.79 | 36.55 | 14.34% |
| 2021-01-16 | 19 | 53 | 36.0 | 41.79 | 36.70 | 13.87% |
| 2021-01-09 | 19 | 53 | 36.0 | 41.79 | 37.13 | 12.55% |
| 2021-01-02 | 19 | 53 | 36.0 | 41.79 | 36.81 | 13.53% |
| 2020-12-26 | 19 | 53 | 36.0 | 41.79 | 37.27 | 12.13% |
| 2020-12-19 | 19 | 53 | 36.0 | 41.89 | 37.68 | 11.17% |
| 2020-12-09 | 19 | 53 | 36.0 | 41.95 | 41.85 | 0.24% |
| 2020-12-07 | 19 | 53 | 36.0 | 41.68 | 41.25 | 1.04% |
| 2020-11-23 | 17 | 53 | 34.1 | 40.44 | 36.52 | 10.73% |
| 2020-11-18 | 17 | 53 | 34.1 | 40.17 | 36.32 | 10.6% |
| 2020-11-09 | 16 | 53 | 35.0 | 41.69 | 39.20 | 6.35% |
| 2020-10-27 | 15 | 53 | 35.0 | 41.33 | 37.43 | 10.42% |
| 2020-10-05 | 13 | 53 | 35.0 | 41.77 | NA | NA% |
| 2020-09-06 | 12 | 53 | 35.0 | 42.08 | NA | NA% |
| 2020-08-12 | 13 | 53 | 35.0 | 41.69 | NA | NA% |
| 2020-07-30 | 13 | 53 | 35.0 | 41.69 | NA | NA% |
| 2020-07-22 | 13 | 53 | 35.0 | 40.23 | NA | NA% |
| 2020-06-26 | 13 | 53 | 35.0 | 40.00 | NA | NA% |
| 2020-06-16 | 12 | 53 | 35.0 | 40.17 | NA | NA% |
| 2020-06-08 | 11 | 53 | 35.0 | 40.27 | NA | NA% |
PFE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 2 | 5 | 16 | 0 | 0 | 23 |
The Trend in the Broker Recommendations
PFE's average broker recommendation rating worsened by 0.02 over the prior 153 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of PFE is higher than 94.37% of all US stocks.
- PFE has a higher upside potential (average analyst target price relative to current price) than 8.68% of Pharmaceutical Products stocks.
- Pfizer Inc's average analyst price target is higher than 13.11% of stocks in the mega market cap category.
- The variance in analysts' estimates of PFE is lower than 24.26% of all US stocks.
In the Pharmaceutical Products industry, ACAD, TLRY and ICPT are the three stocks most similar to Pfizer Inc regarding the price target and analyst recommendation information presented here.
Is PFE a Buy, Hold or Sell? See the POWR Ratings now!